Assessment of prolactin release in pituitary dwarfism with the sulpiride test. 1978

M L Batrinos, and S N Pavlou, and S A Pitoulis, and A P Sfikaki, and C Anousakis, and T K Alexandrides, and G P Piaditis

We report here the results obtained with a new test of prolactin (PRL) release in six normal pre-pubertal boys, eleven children with short stature of non-pituitary origin and in thirteen pituitary dwarfs. The test consists of the administration of 100 mg of sulpiride i.m. and the measurement of PRL in serum samples up to 120 min after injection. Baseline PRL concentrations were not clearly different in the three groups. After sulpiride a marked increase (3--10 times over control values) in PRL was noted in all normal and short children without pituitary disease. A complete failure of response was observed in ten of the thirteen pituitary dwarfs. It is concluded that sulpiride has considerable potential in the differential diagnosis of children with stunted growth.

UI MeSH Term Description Entries
D008297 Male Males
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004393 Dwarfism, Pituitary A form of dwarfism caused by complete or partial GROWTH HORMONE deficiency, resulting from either the lack of GROWTH HORMONE-RELEASING FACTOR from the HYPOTHALAMUS or from the mutations in the growth hormone gene (GH1) in the PITUITARY GLAND. It is also known as Type I pituitary dwarfism. Human hypophysial dwarf is caused by a deficiency of HUMAN GROWTH HORMONE during development. Growth Hormone Deficiency Dwarfism,Hypophysial Dwarf,Hyposomatotrophic Dwarfism,Pituitary Dwarf,Dwarfism, Growth Hormone Deficiency,Isolated GH Deficiency,Isolated Growth Hormone Deficiency,Isolated HGH Deficiency,Isolated Human Growth Hormone Deficiency,Isolated Somatotropin Deficiency,Isolated Somatotropin Deficiency Disorder,Nanism, Pituitary,Pituitary Dwarfism,Pituitary Nanism
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013469 Sulpiride A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed) Aiglonyl,Arminol,Deponerton,Desisulpid,Digton,Dogmatil,Dolmatil,Eglonyl,Ekilid,Guastil,Lebopride,Meresa,Pontiride,Psicocen,Sulp,Sulperide,Sulpitil,Sulpivert,Sulpor,Synédil,Tepavil,Vertigo-Meresa,neogama,vertigo-neogama,Vertigo Meresa,vertigo neogama

Related Publications

M L Batrinos, and S N Pavlou, and S A Pitoulis, and A P Sfikaki, and C Anousakis, and T K Alexandrides, and G P Piaditis
January 1980, Endokrynologia Polska,
M L Batrinos, and S N Pavlou, and S A Pitoulis, and A P Sfikaki, and C Anousakis, and T K Alexandrides, and G P Piaditis
June 1975, Bollettino della Societa italiana di biologia sperimentale,
M L Batrinos, and S N Pavlou, and S A Pitoulis, and A P Sfikaki, and C Anousakis, and T K Alexandrides, and G P Piaditis
July 1978, Fertility and sterility,
M L Batrinos, and S N Pavlou, and S A Pitoulis, and A P Sfikaki, and C Anousakis, and T K Alexandrides, and G P Piaditis
February 1974, Nihon Naibunpi Gakkai zasshi,
M L Batrinos, and S N Pavlou, and S A Pitoulis, and A P Sfikaki, and C Anousakis, and T K Alexandrides, and G P Piaditis
May 1974, Minerva pediatrica,
M L Batrinos, and S N Pavlou, and S A Pitoulis, and A P Sfikaki, and C Anousakis, and T K Alexandrides, and G P Piaditis
October 1976, Bollettino della Societa italiana di biologia sperimentale,
M L Batrinos, and S N Pavlou, and S A Pitoulis, and A P Sfikaki, and C Anousakis, and T K Alexandrides, and G P Piaditis
November 1981, Acta endocrinologica,
M L Batrinos, and S N Pavlou, and S A Pitoulis, and A P Sfikaki, and C Anousakis, and T K Alexandrides, and G P Piaditis
January 1992, Journal de gynecologie, obstetrique et biologie de la reproduction,
M L Batrinos, and S N Pavlou, and S A Pitoulis, and A P Sfikaki, and C Anousakis, and T K Alexandrides, and G P Piaditis
November 1974, Helvetica paediatrica acta,
M L Batrinos, and S N Pavlou, and S A Pitoulis, and A P Sfikaki, and C Anousakis, and T K Alexandrides, and G P Piaditis
November 1974, Experientia,
Copied contents to your clipboard!